Shaping the future of animal health
Virbac group

A company dedicated
to animal health

Founded in 1968 by a French veterinarian, Virbac is an independent pharmaceutical company exclusively dedicated to animal health. Ranked 8th worldwide and present in more than 100 countries, the company offers a comprehensive range of products and services intended for veterinarians, farmers and animal owners.

Corporate news

Mar 12 - New tagline: Virbac shows its ambition!

“Shaping the future of animal health”. This is now Virbac's new tagline, replacing “Passionate about animal health”, launched in 2001. What message does this new slogan convey? Answers from Sandrine Brunel, head of Corporate Communications.

Feb 20 - VDS: Virbac's commitment to the dairy sector

At the beginning of October the GMBO (Global Marketing) organized the first Virbac Dairy Symposium in France, attended by experts from the dairy sector and Virbac staff from all over the world. Fabrice Payot, Global Marketing manager on the dairy cattle segment, explains the objectives of this major event.   

Jan 09 - St. Louis: to better serve product innovation

Virbac United States inaugurates the April 20th, 2014 a new building for its R&D activities. With which objectives? The answers from R&D vice-president of the American subsidiary.

Join Virbac

Career opportunities, company values, testimonials... Discover our career section.

Customer driven innovation

To meet the customers' essential needs, in almost all the therapeutic segments and for nearly all species. Such is the philosophy of Virbac innovation. For this purpose, the company develops...

Financial public releases

Apr 15 - 2015 first quarter consolidated sales

  Sales growth of 17.1% in the first quarter

Mar 24 - PEA-PME eligibility of Virbac

Virbac, listed on Euronext Paris

Mar 16 - 2014 annual results

  Results grow in 2014 following a strong second half

Corporate responsibility

Company culture, economic and social responsibility, citizenship, environment... From its very beginning, forty years ago, Virbac has taken a long-term view.